Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Amag Pharmaceuticals (NQ: AMAG )

13.75 USD UNCHANGED
Last Price Updated: 4:06 PM EST, Nov 13, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Amag Pharmaceuticals

< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
50 51 Next >
Autodesk, SCANA, And 3 Other Stocks With Clear Trading Opportunities This Week
Below are five stocks to watch according to VantagePoint, a platform that uses artificial intelligence and Intermarket analysis to ... 
Tags vantagepoint Biotech Short Ideas
From Benzinga
The Market In 5 Minutes: AXA Buys XL Group, Biotech Preview, Small Banks
IN THE NEWS The upcoming week has to plenty to offer by way of catalysts that can make or break a stock. Stay tuned to these key ... 
Tags Market in 5 minutes XL Top Stories
From Benzinga
AMAG Pharmaceuticals to Present at Upcoming Investor Conferences
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that company management will participate in the following investor conferences: 
From GlobeNewswire News Releases
Amag Pharmaceuti Up 19.2% Since SmarTrend Uptrend Call (AMAG)
SmarTrend identified an Uptrend for Amag Pharmaceuti (NASDAQ:AMAG) on February 15th, 2018 at $17.20. In approximately 2 weeks, Amag Pharmaceuti has returned 19.19% as of today's recent price of... 
From Comtex SmarTrend® News Briefs
Stocks With Rising Relative Price Strength: AMAG Pharmaceuticals
AMAG Pharmaceuticals shows improving price performance, earning an upgrade to its IBD Relative Strength Rating. 
From Investor's Business Daily
BRIEF-AMAG Reports Q4 Earnings Of $0.10 Per Share
* TOTAL GAAP REVENUES FOR Q4 OF 2017 WERE $158.3 MILLION, COMPARED WITH $151.6 MILLION 
Tags companyNews
From Reuters: Company News
AMAG Reports 2017 Financial Results and Company Update
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today reported unaudited consolidated financial results for the fourth quarter and full year ended December 31, 2017. 
From GlobeNewswire News Releases
AMAG Pharmaceuticals Earns Relative Strength Rating Upgrade; Hits Key Benchmark
A Relative Strength Rating upgrade for AMAG Pharmaceuticals shows improving technical performance. 
From Investor's Business Daily
First Week of April 20th Options Trading For AMAG Pharmaceuticals (AMAG)
Investors in AMAG Pharmaceuticals, Inc. (AMAG) saw new options become available this week, for the April 20th expiration.. 
Tags Stocks
From Market News Video
These 2 Biotech Stocks Are Soaring. Can They Keep It Up?
Tags DSNKY BGNE AMAG
From Motley Fool
AMAG Pharmaceuticals Shows Rising Relative Price Performance; Still Shy Of Key Threshold
AMAG Pharmaceuticals shows improving price performance, earning an upgrade to its IBD Relative Strength Rating 
From Investor's Business Daily
AMAG Pharmaceuticals to Host Fourth Quarter and Full Year 2017 Financial Results Conference Call and Webcast on Tuesday, February 27, 2018 at 8:00 a.m. ET
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that its fourth quarter and full year 2017 financial results will be released on Tuesday, February 27, 2018 before the U.S. financial markets... 
From GlobeNewswire News Releases
Blog Exposure - FDA Granted Approval to AMAG’s Makena(R) Subcutaneous Auto-Injector to Reduce the Risk of Preterm Birth in Certain At-risk Women
From ACCESSWIRE
AMAG Crosses Above Average Analyst Target
In recent trading, shares of AMAG Pharmaceuticals, Inc. (AMAG) have crossed above the average analyst 12-month target price of $17.40, changing hands for $17.90/share.. 
Tags ETFs
From ETF Channel
32 Stocks Moving In Friday's Pre-Market Session
Gainers Synchronoss Technologies, Inc. (NASDAQ: SNCR) rose 32 percent to $9.87 in pre-market trading. Synchronoss reported ... 
Tags DCIX IO Health Care
From Benzinga
Recent Analysis Shows SBA Communications, AMAG Pharmaceuticals, Galectin Therapeutics, Xilinx, J.B. Hunt Transport Services, and Southern Market Influences — Renewed Outlook, Key Drivers of Growth
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of SBA Communications... 
From GlobeNewswire News Releases
46 Biggest Movers From Yesterday
Gainers Yangtze River Port and Logistics Ltd (NASDAQ: YRIV) shares climbed 36.92 percent to close at $4.45 on ... 
Tags NSPR TRTN ALNA
From Benzinga
Market rally continues despite gain in producer prices
The markets continued to rally with the Dow rocketing 306 points to close at 25,200 despite a gain in producer prices. Nasdaq leaped 112 points to 7256. 
Tags Market News
From MarketMinute.com Market Updates
FDA approves AMAG's and Antares' injector
The Food and Drug Administration approved the Makena subcutaneous auto injector that was developed by AMAG Pharmaceuticals Inc. (Nasdaq: AMAG) and Antares Pharma Inc. (Nasdaq: ATRS). Shares of AMAG... 
From MarketMinute.com Stock News
Mid-Afternoon Market Update: Build-A-Bear Surges On Upbeat Earnings; Inpixon Shares Drop
Toward the end of trading Thursday, the Dow traded up 0.42 percent to 24,997.05 while the NASDAQ climbed 0.86 percent to 7,205.21. The ... 
Tags SYNT Information Technology CAI
From Benzinga
Why AMAG Pharmaceuticals, Inc. (AMAG) Shares Are Skyrocketing Today
 
Tags NASDAQ:AMAG Hot Stocks
From InvestorPlace
Mid-Day Market Update: SolarEdge Technologies Gains Following Q4 Earnings Beat; Avid Bioservices Shares Slide
Midway through trading Thursday, the Dow traded up 0.27 percent to 24,960.45 while the NASDAQ climbed 0.67 percent to 7,191.27. The ... 
Tags INPX SPWR Commodities
From Benzinga
This Biotech Stock Pops 30% On FDA Nod — 'Slamming Door' On Woes
Amag increased its value by nearly a third Thursday after U.S. regulators approved a second drug from the biotech this month. 
From Investor's Business Daily
40 Stocks Moving In Thursday's Mid-Day Session
Gainers AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) shares climbed 27.34 percent to $17.70 after the pharmaceutical company ... 
Tags ADMP NTAP INPX
From Benzinga
Why AMAG Pharmaceuticals, Inc. and Antares Pharma, Inc. Are Soaring Today
Tags ATRS AMAG
From Motley Fool
Mid-Morning Market Update: Markets Open Higher; Cisco Profit Tops Estimates
Following the market opening Thursday, the Dow traded up 0.64 percent to 25,052.78 while the NASDAQ climbed 0.80 percent to 7,200.67. ... 
Tags SYNT Eurozone Commodities
From Benzinga
Benzinga's Top Upgrades, Downgrades For February 15, 2018
Top Upgrades Analysts at Morgan Stanley upgraded Baidu, Inc. (NASDAQ: BIDU) from Equal-Weight to Overweight. Baidu shares ... 
Tags GE BMO SEDG
From Benzinga
Amag Pharmaceuti Up on Heavy Volume in Possible Trend Reversal (AMAG)
Amag Pharmaceuti shares are trading on heavy volume today, having risen 18.3% to $16.45. About 2.5 million shares have been traded today, as compared to the 30-day average volume... 
From Comtex SmarTrend® News Briefs
22 Stocks Moving In Thursday's Pre-Market Session
Gainers AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) shares rose 19.4 percent to $16.60 in pre-market trading after the ... 
Tags Markets Movers & Shakers CTL
From Benzinga
Benzinga Pro's 5 Stocks To Watch Today
Each day, the Benzinga Pro news team highlights several stocks with Trading Idea potential. Be the first to see them by becoming a ... 
Tags TRIP News AMAG
From Benzinga
< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
50 51 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.